Rheumatologist Salary (2026): What Rheumatologists Earn, How Infusions Pay, and Whether the Fellowship Pays Off

Rheumatologist salary in 2026, by source

The sources put the middle of rheumatology pay between about $285,000 and $350,000. The spread comes from the samples. Medscape's rheumatology average drew partly on its 2024 survey responses, which helps explain why it didn't move from the year before. Doximity's much larger panel is the better guide to typical full-time pay; SalaryDr's 60 self-reports skew toward people who track and negotiate their pay, so read its middle half as what a strong offer looks like.

Is rheumatologist pay going up?

Yes, according to the employer surveys. SullivanCotter's 2026 survey, built from health system payroll, shows rheumatology with the largest one-year increase of any specialty, 10.4%, in a year when adult medical specialties overall rose 7.2%. MGMA's 2026 data shows +6.3%. SullivanCotter's data come mainly from health systems, so its increase reflects what employers are paying to recruit into a shrinking workforce. A single year's change in any survey is noisy, but two independent employer surveys agreeing on direction is a meaningful signal.

Rheumatologist pay vs. internal medicine and other fellowships

Rheumatology sits with the other cognitive medicine fellowships: above endocrinology, below infectious disease and nephrology, and $17,496 under the general internist average on Doximity. The work is outpatient evaluation and management of chronic inflammatory disease, paid at the same visit rates as primary care, with few procedures beyond joint injections and ultrasound.

How rheumatologists are paid

1. Base salary, usually guaranteed for the first one to three years of an employed contract.
2. Productivity bonus per wRVU above a threshold. SalaryDr's rheumatologists report a $60 median rate (middle half $50 to $61, 54 reports), above the $51 internists report on the same site.
3. Procedures and ancillaries: joint aspirations and injections, musculoskeletal ultrasound, bone density, and in-office labs where the practice owns them.
4. Infusion revenue, covered in the next section; it goes to whoever owns the infusion suite.
5. Call, which is usually light and often unpaid; inpatient consult coverage varies by hospital.

The rate matters. At the SalaryDr median, a $350,000 income at $60 per wRVU implies about 5,800 wRVUs a year. The same volume at the $51 internist rate pays $295,800, a difference of $54,200. An employer that offers a primary care rate for rheumatology work is offering a pay cut. Compare offers with our pay per wRVU by specialty data.

Infusions, biologics and rheumatology income

Many rheumatology patients take biologic drugs given by infusion in a clinic. A practice that runs its own infusion suite buys the drug ("buy and bill"), and Medicare Part B pays most physician-administered drugs at the drug's average sales price plus 6%, a rate set by statute in 2003. The 2% Medicare sequestration trims the add-on to roughly 4.3%. On top of that, the practice bills an administration fee for the infusion itself.

• Who keeps it. In private groups, infusion margin and administration fees flow to the practice and its partners. In hospital-employed jobs, infusions usually run through a hospital outpatient department, and the revenue stays with the hospital rather than the rheumatologist's wRVU pool.
• The margin is thin and risky. The add-on is a percentage of the drug price, so it shrinks as biosimilars lower prices, and the practice carries the drug inventory and the risk of denied claims.
• Price negotiation is reaching Part B. Orencia (abatacept), a rheumatology infusion, is one of 15 drugs selected for the third cycle of Medicare drug price negotiation, the first to include drugs paid mainly under Part B. A lower negotiated price lowers the dollar value of the add-on.

We couldn't verify a published figure for what infusion ownership adds to a rheumatologist's income, and it varies by drug mix and payer. If an offer includes partnership in a group with an infusion center, ask for the infusion line's revenue and expenses for the last three years.

Rheumatologist salary by practice setting

SalaryDr's self-reported medians are close across settings, with academic and private practice slightly ahead of hospital employment. The samples are small enough that the order could change with a few reports. Older survey data reported larger private-practice premiums, which fits the infusion economics above, but we couldn't verify a current figure.

• Academic: teaching and research time, PSLF-eligible employers, and pay that often includes a non-clinical component.
• Hospital-employed: base plus wRVU bonus, benefits and malpractice covered, PSLF if the system is a nonprofit; infusion revenue usually stays with the hospital.
• Private practice: partnership income including infusions and ancillaries, after a partnership track and buy-in; see our partnership buy-in guide.

Rheumatologist hours and pay per hour

SalaryDr's 60 rheumatologists report about 43 hours a week, rate satisfaction 3.8 out of 5, and 95% would choose rheumatology again. Per hour, that's about 17% more than a general internist earns on the same data. The hidden hours are in prior authorizations for biologics and between-visit monitoring of immunosuppressed patients.

Rheumatologist take-home pay by state

The same salary leaves about $30,016 more a year in Texas than in California. We didn't find a verified rheumatology-specific regional pay survey with a usable sample. Run your numbers in the take-home pay calculator and see physician salary by state.

Is a rheumatology fellowship worth it financially?

Using the method from our is a fellowship worth it guide: the internist starts practice after residency; the rheumatologist spends two years at fellow stipends ($77,593 and $81,807, AAMC 2025 PGY-4 and PGY-5 means), then earns the rheumatology figure. Both work 30 years after residency, single, in Texas, discounted at 3% a year.

• On Doximity's averages it never pays back: the rheumatologist earns $17,496 a year less than the internist, so the $349,766 after-tax cost of fellowship grows to $656,681 over a career.
• On SalaryDr's medians it pays back late: about 24.4 years after fellowship, and the present value is still -$77,380 because the payback comes so late. The fellowship needs about $30,203 a year over the internist average to break even in present value.
• Against hospital medicine, where SalaryDr's median is $345,000, the fellowship isn't recovered in 30 years. What it buys is a clinic schedule instead of shifts.

Two things could change this: pay growth like SullivanCotter's 10.4% continuing for several years, or a private practice job with infusion and partnership income. Neither is guaranteed. Model your own case in the specialty ROI calculator.

Student loans and PSLF for rheumatologists

Our student loan hub's model ($215,000, the AAMC median debt for indebted 2025 graduates, at 6.5%; payments from the start of residency; single; Doximity average pay after training):

Five of the ten PSLF years fall in training, so the rheumatologist pays about $55,883 less than the internist on IBR and has about $196,882 forgiven. Without PSLF, paying off on the 10-year Standard plan after training costs about $379,945 ($2,977 a month). That makes the employer type one of the biggest financial choices in rheumatology: an academic or nonprofit hospital job with PSLF can be worth more than a private-practice offer paying somewhat more. See does my hospital qualify for PSLF and PSLF vs. refinancing.

The rheumatologist shortage and job market

Rheumatology's shortage is a supply problem, not a recruiting one. Fellowships fill almost completely; there just aren't enough of them to replace retiring rheumatologists while an aging population brings more inflammatory arthritis and autoimmune disease. The ACR study pointed to retirements and more part-time work as the drivers of the projected fall in clinical supply. HRSA's newer model is less severe, at 91% of demand in 2038, but still short.

For a new rheumatologist, that means leverage, especially in regions far from academic centers: ask for a signing bonus, loan repayment, a protected template and a shorter partnership track. It's also the likeliest explanation for the 10.4% pay increase in SullivanCotter's data.

Pediatric rheumatologist salary

Pediatric rheumatology averaged $236,011 in Doximity's 2026 report ($231,574 in 2025), one of the three lowest-paid specialties it tracks, after pediatrics residency and a three-year fellowship. The field is small and concentrated in children's hospitals and academic centers, nearly all PSLF-eligible. See our pediatrician salary guide and the pediatric rows of the fellowship guide.

Negotiating a rheumatology offer

1. wRVU rate. Compare it with the $60 SalaryDr median (middle half $50 to $61), not with a primary care rate.
2. Infusion economics. Who owns the infusion suite, whether any of its revenue reaches you, and, for a partnership track, the infusion line's recent profit.
3. Procedure and ultrasound credit. Whether injections and musculoskeletal ultrasound count toward your production, and who pays for the machine.
4. Prior authorization support. Biologics need constant authorizations; ask how many staff handle them.
5. Template and new-patient wait. A long waitlist is leverage. Ask for visit lengths that fit complex autoimmune patients.
6. Recruiting incentives. Signing bonus, loan repayment and relocation, especially where the shortage is worst.
7. Non-compete and PSLF. Read our non-compete guide and contract red flags, and confirm the employer qualifies for PSLF.

Use our contract analyzer to compare offers, and our salary negotiation and signing bonus guides before you respond.

Sources

1. Doximity Physician Compensation Report 2026 (rheumatology $321,778, pediatric rheumatology $236,011, internal medicine $339,274) and the 2025 report (pediatric rheumatology $231,574).
2. Medscape Physician Compensation Report 2026; sample, survey dates and the rheumatology note via Becker's ASC.
3. SalaryDr: rheumatology salaries, pay by practice setting, wRVU rates and lifestyle survey; internal medicine and hospitalist medians from SalaryDr. Self-reported; read October 2026.
4. SullivanCotter 2026 Physician Compensation and Productivity Survey, via Medical Economics, September 2026.
5. MGMA 2026 Provider Compensation data, one-year change by specialty, via Marit Health.
6. Battafarano et al. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030, Arthritis Care & Research, 2018.
7. Physician workforce projections fact sheet, HRSA, December 2025; Results and Data, Specialties Matching Service 2026, NRMP.
8. Medicare Part B drug payment at ASP plus 6% and the sequestration effect: Health Affairs Health Policy Brief; third-cycle negotiation drugs including Orencia: Milliman and Health Affairs Forefront, 2026.
9. AAMC 2025 Survey of Resident/Fellow Stipends and Benefits, as tabulated in our resident salary guide; fellowship length from the ACGME program requirements for rheumatology.
10. Take-home pay, fellowship and loan figures: computed from our 2026 tax model and student loan model.